BDNF alters ERK/p38 MAPK activity ratios to promote differentiation in growth plate chondrocytes

Molecular Endocrinology

Volumn 26, Issue 8, 2012, Pages 1406-1416

  Hutchison, Michele R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BRAIN DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NATRIURETIC PEPTIDE TYPE C; RAF PROTEIN; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LYSATE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REPRESSION; GROWTH PLATE; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATTLE; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GROWTH PLATE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; NATRIURETIC PEPTIDE, C-TYPE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-RAF;

BOVINAE; MURINAE;

EID: 84864468944     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1063     Document Type: Article

References (33)

1. Hunziker EB 1994 Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microsc Res Tech 28: 505-519
2. Kronenberg HM 2003 Developmental regulation of the growth plate. Nature 423:332-336
3. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH 2001 MAP kinases. Chem Rev 101:2449-2476
4. Cobb MH 1999 MAP kinase pathways. Prog Biophys Mol Biol 71:479-500
5. Johnson GL, Lapadat R 2002 Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912
6. Kyriakis JM, Avruch J 1996 Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18:567-577
7. Robinson MJ, Cobb MH 1997 Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-186
8. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183
9. Hutchison MR, Bassett MH, White PC 2010 SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation. Mol Endocrinol 24:193-203
10. Hutchison MR, Bassett MH, White PC 2007 Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation. Endocrinology 148: 3122-3130
11. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC 1995 SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233
12. Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P 1997 Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J 16:3563-3571
13. Li J, Zhao Z, Liu J, Huang N, Long D, Wang J, Li X, Liu Y 2010 MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-β1/Smads pathway. Cell Prolif 43:333-343
14. Bashey RI, Iannotti JP, Rao VH, Reginato AM, Jimenez SA 1991 Comparison of morphological and biochemical characteristics of cultured chondrocytes isolated from proliferative and hypertrophic zones of bovine growth plate cartilage. Differentiation 46:199-207
15. Olney RC, Smith RL, Kee Y, Wilson DM 1993 Production and hormonal regulation of insulin-like growth factor binding proteins in bovine chondrocytes. Endocrinology 133:563-570
16. Shukunami C, Shigeno C, Atsumi T, Ishizeki K, Suzuki F, Hiraki Y 1996 Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J Cell Biol 133:457-468
17. Hall-Jackson CA, Goedert M, Hedge P, Cohen P 1999 Effect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene 18:2047-2054
18. Agoston H, Khan S, James CG, Gillespie JR, Serra R, Stanton LA, Beier F 2007 C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and-independent pathways. BMC Dev Biol 7:18
19. Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H, Wilcox WR 2005 Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci 118:5089-5100
20. Kalmes A, Deou J, Clowes AW, Daum G 1999 Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580. FEBS Lett 444:71-74
21. Stanton LA, Sabari S, Sampaio AV, Underhill TM, Beier F 2004 A p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J 378:53-62
22. Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F 1999 p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp Cell Res 250:351-363
23. Bobick BE, Kulyk WM 2004 The MEK-ERK signaling pathway is a negative regulator of cartilage-specific gene expression in embryonic limb mesenchyme. J Biol Chem 279:4588-4595
24. Murakami S, Balmes G, McKinney S, Zhang Z, Givol D, de Crombrugghe B 2004 Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev 18:290-305
25. Matsushita T, Chan YY, Kawanami A, Balmes G, Landreth GE, Murakami S 2009 Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol Cell Biol 29:5843-5857
26. Engelman JA, Lisanti MP, Scherer PE 1998 Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 273:32111-32120
27. Sale EM, Atkinson PG, Sale GJ 1995 Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 14:674-684
28. Morooka T, Nishida E 1998 Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J Biol Chem 273:24285-24288
29. O'Brien LE, Tang K, Kats ES, Schutz-Geschwender A, Lipschutz JH, Mostov KE 2004 ERK and MMPs sequentially regulate distinct stages of epithelial tubule development. Dev Cell 7:21-32
30. Albig AR, Schiemann WP 2005 Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling. Mol Biol Cell 16:609-625
31. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN 2004 Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428: 185-189
32. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, Shaw PE 1995 ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 14: 951-962
33. Bennett AM, Tonks NK 1997 Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278:1288-1291